A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT04073615 · TERMINATED
Trial details
- NCT number
- NCT04073615
- Sponsor
- Elevar Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-18
- Primary completion
- 2023-05-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.